BRIEF published on 04/16/2025 at 11:05, 1 year 4 months ago Vision Marine and STERK Enhance Electric Boat Integration Electric Propulsion Vision Marine STERK Yachts Hull Optimization Boating Innovation
BRIEF published on 04/16/2025 at 11:05, 1 year 4 months ago Vision Marine et STERK améliorent l'intégration des bateaux électriques Vision Marine Propulsion Électrique Innovation Nautique STERK Yachts Optimisation De La Coque
BRIEF published on 04/16/2025 at 10:55, 1 year 4 months ago Travelex Issuerco 2 Plc: Consent Solicitation Outcome Investor Relations Financial Amendments Consent Solicitation Travelex Notes Trust Deeds
BRIEF published on 04/16/2025 at 10:55, 1 year 4 months ago Travelex Issuerco 2 Plc : résultat de la demande de consentement Relations Avec Les Investisseurs Sollicitation De Consentement Billets Travelex Actes De Fiducie Amendements Financiers
BRIEF published on 04/16/2025 at 10:24, 1 year 4 months ago BayWa AG Announces Restructuring Plan Meeting Creditors BayWa AG Restructuring Munich Meeting
BRIEF published on 04/16/2025 at 10:24, 1 year 4 months ago BayWa AG annonce une réunion sur le plan de restructuration BayWa AG Créanciers Munich Restructuration Réunion
BRIEF published on 04/16/2025 at 10:05, 1 year 4 months ago Akara Diversity PK Increases Cash Flow to 3.04% for 2024 Cash Flow Increase Portfolio Strengthening Akara Swiss Diversity Shareholders Equity Strategic Sales
BRIEF published on 04/16/2025 at 10:05, 1 year 4 months ago Akara Diversity PK augmente son flux de trésorerie à 3,04 % pour 2024 Capitaux Propres Augmentation Des Flux De Trésorerie Renforcement Du Portefeuille Akara Diversité Suisse Ventes Stratégiques
BRIEF published on 04/16/2025 at 10:05, 1 year 4 months ago PenKid Biomarker Enhances Kidney Function Assessment in ICU Settings Acute Kidney Injury Biomarker Kidney Function PenKid ICU
BRIEF published on 04/16/2025 at 10:05, 1 year 4 months ago Le biomarqueur PenKid améliore l'évaluation de la fonction rénale en unité de soins intensifs Lésion Rénale Aiguë Unité De Soins Intensifs Biomarqueur PenKid Fonction Rénale
Published on 09/11/2026 at 17:00, 2 hours 57 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours 57 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 4 hours 32 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours 57 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 5 hours 27 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 13 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 1 hour 42 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 1 hour 57 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 12 hours 57 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 12 hours 57 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 12 hours 57 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours 57 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
